Actively Recruiting
Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke
Led by Jukka Putaala · Updated on 2025-03-20
405
Participants Needed
4
Research Sites
515 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The CARDIOSTROKE is a randomized trial comparing mobile-device assisted control of hypertension together with screening of occult atrial fibrillation to standard care in patients with recent ischemic stroke or transient ischemic attack.
CONDITIONS
Official Title
Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ischemic stroke or transient ischemic attack with ABCD2 score 3
- Age 40 years or older
- Pre-existing or newly diagnosed hypertension
- Informed consent from the patient or legal representative
You will not qualify if you...
- Known high-risk source of cardioembolism
- Known indication for anticoagulation
- Contraindication for anticoagulation
- Pacemaker
- Non-compliance to study interventions as judged by the investigator
- Serious condition hampering the study conduct
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Kanta-Häme Central Hospital
Hämeenlinna, Finland
Actively Recruiting
2
Helsinki University Hospital
Helsinki, Finland, 00290
Actively Recruiting
3
Hyvinkää Hospital
Hyvinkää, Finland
Actively Recruiting
4
Päijät-Häme Central Hospital
Lahti, Finland
Actively Recruiting
Research Team
T
Tuomas Lumikari, MD
CONTACT
A
Anu Eräkanto
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here